BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Kn93

a calcium/calmodulin-dependent kinase II inhibitor; Heading Mapped to: Benzylamines Sulfonamides

26+ PubMed studies analyzed · Evidence Score: 36.1

Research Domains

Kn93 has been studied across 14 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🔬 Inflammation, ❤️ Cardiovascular, ⚡ Energy & Fatigue. The primary research focus is 🦴 Bone & Joint with 77% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Kn93, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cerulenin
5 shared targets
Fluvastatin
4 shared targets
Carduus
3 shared targets
Puromycin
5 shared targets
Canagliflozin
4 shared targets
Deferoxamine
5 shared targets
beta
4 shared targets
deguelin
5 shared targets
Teniposide
4 shared targets
casin
4 shared targets
Loading evidence profile...

This evidence profile for Kn93 is generated deterministically from 26 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.